ENDRA Life Sciences Inc(NDRA)

盘后0.2681-0.01-4.25%19:57 EDT

0.2800-0.0219-7.25%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
公司概况
公司名称
ENDRA Life Sciences Inc
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.endrainc.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
恩德拉生命科学公司于2007年7月18日成立为一家特拉华州公司。Endra开发了一种基于热声效应的医学成像技术，显著提高了临床超声的灵敏度和特异性。自2010以来，Endra已经上市出售公司基于结合光的热声和超声成像的Nexus 128系统，以满足研究人员在临床前应用中研究疾病模型的成像需求。
- 08-28
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 08-23
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 08-16
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 08-15
  季度报告
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 08-13
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 08-09
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 07-17
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 06-14
  超过5%披露
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
- 06-14
  超过5%披露
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
- 06-06
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 06-03
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 06-03
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 05-31
  [修订]招股说明书
  Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
  Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
- 05-20
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 05-14
  季度报告
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]